āĻšā§āĻŽD4S âĸ FRA
add
Daiichi Sankyo Co Ltd
⧧⧝.ā§ā§ĻâŦ
⧍ āĻā§āϞ, ā§§ā§§:ā§Ēā§Ŧ:ā§§ā§Š PM GMT +⧍ · EUR · FRA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻDE-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋJP-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
⧧⧝.ā§Ēā§§âŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
⧧⧝.⧍ā§ĢâŦ - ⧧⧝.ā§ā§ĻâŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
⧧⧝.ā§Ļā§§âŦ - ā§Šā§.⧝ā§ĻâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Ēā§Š.⧍ā§ŦāĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧍⧝⧝.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
TYO
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Ģā§§ā§Ž.ā§Ŧ⧝āĻā§ | ⧍⧧.ā§Ļā§% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Šā§Ēā§Ļ.ā§ā§ĒāĻā§ | ā§§ā§§.ā§Ļ⧍% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Žā§.ā§§ā§ĢāĻļāĻ¤Â āĻā§ | ā§§ā§Šā§Ē.ā§Ē⧝% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§§ā§Ŧ.ā§Žā§Ļ | ā§¯ā§Š.ā§Ģā§Ģ% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ā§§ā§Ļā§§.ā§Ģ⧝āĻā§ | ⧍ā§Ļā§.ā§Šā§¯% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | -ā§Ž.ā§Ļ⧝% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Ŧā§Šā§¯.ā§Žā§ĒāĻā§ | -ā§§.ā§§ā§Š% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Š.ā§Ēā§Ŧ āϞāĻž.āĻā§. | -ā§Ļ.ā§§ā§Ē% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§§.ā§Žā§ŠÂ āϞāĻž.āĻā§. | ā§Š.ā§Šā§¯% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§.ā§Ŧā§¨Â āϞāĻž.āĻā§. | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§Žā§Ŧ.ā§Ŧā§Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§Ļ⧍ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ŧ.ā§Ļā§Ŧ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ⧧⧍.⧧⧍% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Žā§.ā§§ā§ĢāĻļāĻ¤Â āĻā§ | ā§§ā§Šā§Ē.ā§Ē⧝% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§ā§¨.⧧⧍āĻļāĻ¤Â āĻā§ | ā§§ā§Ēā§Ļ.ā§Ŧā§Ģ% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§¨.ā§¯ā§ŠāĻļāĻ¤Â āĻā§ | ā§Ēā§Ž.ā§Ļā§Ŧ% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ģā§Ž.ā§Ģā§§āĻļāĻ¤Â āĻā§ | -ā§§,ā§Ē⧍ā§Ē.⧧⧍% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§Ē⧍.ā§Šā§§āĻļāĻ¤Â āĻā§ | -ā§§ā§§ā§Ŧ.ā§Šā§Ē% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§ā§Ļ.ā§Šā§ŠāĻļāĻ¤Â āĻā§ | ā§ā§Šā§.ā§§ā§Ģ% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ā§Žā§¯ā§¯
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
⧧⧝,ā§ā§Ŧā§Ģ